We can buy this stock at 32,33$, In this post we are going to talk about the listed company Neoleukin Therapeutics, its leaders are Daniel-Adriano Silva (Vice President-Research), Jonathan G. Drachman (President, Chief Executive Officer & Director), Priti Patel (Chief Medical Officer), Robert Ho (Chief Financial & Accounting Officer), Umut Ulge (Vice President-Clinical Development), they lead it to work in Biotechnology: Pharmaceutical Preparations especially in the North America region.
The closing price of the stock yesterday was desconocido$.
The current range on the same day is from 32,27$ - 33,96$, with a percentage difference of 33,11$ quite wide that helps to be able to do day trading.
Their latest annual data shows an income of desconocido.
The opening price that appears as last recorded is desconocido.
One of the most interesting values to assess whether the price of a share is low or high is the minimum and maximum price of the last 52 weeks, in this case it has varied between 0,00$ and 0,00$.
Earnings per share, or EPS, is a value also used to assess whether a company has obtained sufficient net profits for the number of shares it has for sale. In this case it is [BPA], but it must be taken into account that there may have been increases or decreases in capital that influence the value.
Buscar
